The emerging role of FGF receptor as a potential target in breast cancer

被引：0
|
作者：
Kahkonen, Tiina [1 ]
Harkonen, Pirkko [1 ]
机构：
[1] Univ Turku, Dept Cell Biol & Anat, FI-20520 Turku, Finland
来源：
BREAST CANCER MANAGEMENT | 2014年 / 3卷 / 03期
关键词：
combination therapy of breast cancer; FGF; FGFR; FGFR dysregulation; FGFR inhibitor; FGFR-targeted therapy; hormone-resistant breast cancer; mammary gland;
D O I：
10.2217/BMT.14.15
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：215 / 218
页数：4
相关论文
共 50 条
  • [31] Role of Urokinase Plasminogen Activator Receptor in Gastric Cancer: A Potential Therapeutic Target
    Ma, Ying-Yu
    Tao, Hou-Quan
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2012, 27 (05) : 285 - 290
  • [32] AXL receptor as an emerging molecular target in colorectal cancer
    De Rosa, Lucia
    Di Stasi, Rossella
    Fusco, Virginia
    D'Andrea, Luca D.
    DRUG DISCOVERY TODAY, 2024, 29 (06)
  • [33] FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium
    Agarwal, D.
    Pineda, S.
    Michailidou, K.
    Herranz, J.
    Pita, G.
    Moreno, L. T.
    Alonso, M. R.
    Dennis, J.
    Wang, Q.
    Bolla, M. K.
    Meyer, K. B.
    Menendez-Rodriguez, P.
    Hardisson, D.
    Mendiola, M.
    Gonzalez-Neira, A.
    Lindblom, A.
    Margolin, S.
    Swerdlow, A.
    Ashworth, A.
    Orr, N.
    Jones, M.
    Matsuo, K.
    Ito, H.
    Iwata, H.
    Kondo, N.
    Hartman, M.
    Hui, M.
    Lim, W. Y.
    Iau, P. T-C
    Sawyer, E.
    Tomlinson, I.
    Kerin, M.
    Miller, N.
    Kang, D.
    Choi, J-Y
    Park, S. K.
    Noh, D-Y
    Hopper, J. L.
    Schmidt, D. F.
    Makalic, E.
    Southey, M. C.
    Teo, S. H.
    Yip, C. H.
    Sivanandan, K.
    Tay, W-T
    Brauch, H.
    Bruening, T.
    Hamann, U.
    Dunning, A. M.
    Shah, M.
    BRITISH JOURNAL OF CANCER, 2014, 110 (04) : 1088 - 1100
  • [34] FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium
    D Agarwal
    S Pineda
    K Michailidou
    J Herranz
    G Pita
    L T Moreno
    M R Alonso
    J Dennis
    Q Wang
    M K Bolla
    K B Meyer
    P Menéndez-Rodríguez
    D Hardisson
    M Mendiola
    A González-Neira
    A Lindblom
    S Margolin
    A Swerdlow
    A Ashworth
    N Orr
    M Jones
    K Matsuo
    H Ito
    H Iwata
    N Kondo
    M Hartman
    M Hui
    W Y Lim
    P T-C Iau
    E Sawyer
    I Tomlinson
    M Kerin
    N Miller
    D Kang
    J-Y Choi
    S K Park
    D-Y Noh
    J L Hopper
    D F Schmidt
    E Makalic
    M C Southey
    S H Teo
    C H Yip
    K Sivanandan
    W-T Tay
    H Brauch
    T Brüning
    U Hamann
    A M Dunning
    M Shah
    British Journal of Cancer, 2014, 110 : 1088 - 1100
  • [35] The Role of Transient Receptor Potential Melastatin 7 (TRPM7) in Cell Viability: A Potential Target to Suppress Breast Cancer Cell Cycle
    Liu, Hengrui
    Dilger, James P.
    Lin, Jun
    CANCERS, 2020, 12 (01)
  • [36] TRANSIENT RECEPTOR POTENTIAL (TRP) CHANNEL: AN EMERGING TARGET FOR PAIN
    Khot, S. S.
    Shaikh, H. Y.
    Patil, R. S.
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2013, 4 (06): : 2035 - 2044
  • [37] Metabotropic glutamate receptor-1: a potential therapeutic target for the treatment of breast cancer
    Cecilia L. Speyer
    Jennifer S. Smith
    Malathi Banda
    John A. DeVries
    Tassia Mekani
    David H. Gorski
    Breast Cancer Research and Treatment, 2012, 132 : 565 - 573
  • [38] Metabotropic glutamate receptor-1: a potential therapeutic target for the treatment of breast cancer
    Speyer, Cecilia L.
    Smith, Jennifer S.
    Banda, Malathi
    DeVries, John A.
    Mekani, Tassia
    Gorski, David H.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 132 (02) : 565 - 573
  • [39] Structure and function of β-arrestins, their emerging role in breast cancer, and potential opportunities for therapeutic manipulation
    Shukla, Arun K.
    Dwivedi-Agnihotri, Hemlata
    GPCR SIGNALING IN CANCER, 2020, 145 : 139 - 156
  • [40] Estrogen receptor as a target for the prevention of breast cancer
    Jordan, VC
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1999, 133 (05): : 408 - 414
12345